Health Equity and Inclusiveness Lung Cancer Translational Research Awards - LOI

Sponsor Deadline: 

Feb 24, 2021

Letter of Intent Deadline: 

Feb 24, 2021

Sponsor: 

LUNGevity Foundation

UI Contact: 

LUNGevity’s Health Equity and Inclusiveness Junior Investigator Lung Cancer Translational Research Award supports physician-scientists interested in conducting lung cancer clinical research and bridging health disparities by engaging underserved communities or underrepresented minorities.
url   https://lungevity.org/our-research/translational-science-research-grant-programs/applying-for-lungevity-grant/2021-2  
Due Feb. 24, 2021:  Letter of intent (LOI) required

LUNGevity’s Health Equity and Inclusiveness Research Fellow Awards for Lung Cancer Translational Research program supports fellows interested in lung cancer research who belong to underrepresented minorities in STEM.
url  https://lungevity.org/our-research/translational-science-research-grant-programs/applying-for-lungevity-grant/2021-3
Due Feb. 24, 2021:  Letter of intent (LOI) required

LUNGevity’s Early Detection Award for Lung Cancer Translational Research program supports the development of strategies for the early detection and/or diagnosis of lung cancer.
url  https://lungevity.org/our-research/translational-science-research-grant-programs/applying-for-lungevity-grant/2021-0
LOI due Feb. 24, 2021

LUNGevity’s VA Research Scholar Award Program in Lung Cancer Translational Research program supports fellows interested in lung cancer research within the Department of Veterans Affairs.
url   https://lungevity.org/our-research/translational-science-research-grant-programs/applying-for-lungevity-grant/2021-1 
LOI due Feb. 24, 2021

Categories: 

Keywords: